Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Volker Daniel

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
BMC Immunology|March 6, 2019
Patients with idiopathic recurrent miscarriage have abnormally high TGFß+ blood NK, NKT and T cells in the presence of abnormally low TGFß plasma levelsLi Zhu, Mostafa Aly, Ruben Jeremias Kuon, et al.
Transplantation|July 23, 2009
Association of pretransplant soluble glycoprotein 130 (sgp130) plasma levels and posttransplant acute tubular necrosis in renal transplant recipientsMahmoud Sadeghi, Volker Daniel, Imad Lahdou, et al.
Human Immunology|August 25, 2010
Increased pretransplantation plasma kynurenine levels do not protect from but predict acute kidney allograft rejectionImad Lahdou, Mahmoud Sadeghi, Volker Daniel, et al.
The Journal of Allergy and Clinical Immunology|April 9, 2013
Whole-exome sequencing links caspase recruitment domain 11 (CARD11) inactivation to severe combined immunodeficiencyJohann Greil, Tobias Rausch, Thomas Giese, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 5, 2005
ATG induction therapy: long-term effects on Th1 but not on Th2 responsesRolf Weimer, Anne Staak, Caner Süsal, et al.
Cancers|October 3, 2020
Assessment of CAR T Cell Frequencies in Axicabtagene Ciloleucel and Tisagenlecleucel Patients Using Duplex Quantitative PCRMaria-Luisa Schubert, Alexander Kunz, Anita Schmitt, et al.
Human Immunology|October 11, 2012
Increased serum levels of quinolinic acid indicate enhanced severity of hepatic dysfunction in patients with liver cirrhosisImad Lahdou, Mahmoud Sadeghi, Hani Oweira, et al.
International Journal of Molecular Sciences|December 23, 2022
Metabolic Effect of Blocking Sodium-Taurocholate Co-Transporting Polypeptide in Hypercholesterolemic Humans with a Twelve-Week Course of Bulevirtide-An Exploratory Phase I Clinical TrialFelicitas Stoll, Andrea Seidel-Glätzer, Ina Burghaus, et al.
Frontiers in Immunology|December 29, 2025
Long-term compromised immune regulation after rituximab induction in blood group incompatible (ABOi) living-donor renal transplantation - 5 year results of a prospective pilot studyRolf Weimer, Hristos Karakizlis, Fabrice Renner, et al.
BMC Cancer|August 31, 2017
A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocolJacek Hajda, Monika Lehmann, Ottheinz Krebs, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
BMC Immunology|March 6, 2019
Patients with idiopathic recurrent miscarriage have abnormally high TGFß+ blood NK, NKT and T cells in the presence of abnormally low TGFß plasma levelsLi Zhu, Mostafa Aly, Ruben Jeremias Kuon, et al.
Transplantation|July 23, 2009
Association of pretransplant soluble glycoprotein 130 (sgp130) plasma levels and posttransplant acute tubular necrosis in renal transplant recipientsMahmoud Sadeghi, Volker Daniel, Imad Lahdou, et al.
Human Immunology|August 25, 2010
Increased pretransplantation plasma kynurenine levels do not protect from but predict acute kidney allograft rejectionImad Lahdou, Mahmoud Sadeghi, Volker Daniel, et al.
The Journal of Allergy and Clinical Immunology|April 9, 2013
Whole-exome sequencing links caspase recruitment domain 11 (CARD11) inactivation to severe combined immunodeficiencyJohann Greil, Tobias Rausch, Thomas Giese, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|February 5, 2005
ATG induction therapy: long-term effects on Th1 but not on Th2 responsesRolf Weimer, Anne Staak, Caner Süsal, et al.
Cancers|October 3, 2020
Assessment of CAR T Cell Frequencies in Axicabtagene Ciloleucel and Tisagenlecleucel Patients Using Duplex Quantitative PCRMaria-Luisa Schubert, Alexander Kunz, Anita Schmitt, et al.
Human Immunology|October 11, 2012
Increased serum levels of quinolinic acid indicate enhanced severity of hepatic dysfunction in patients with liver cirrhosisImad Lahdou, Mahmoud Sadeghi, Hani Oweira, et al.
International Journal of Molecular Sciences|December 23, 2022
Metabolic Effect of Blocking Sodium-Taurocholate Co-Transporting Polypeptide in Hypercholesterolemic Humans with a Twelve-Week Course of Bulevirtide-An Exploratory Phase I Clinical TrialFelicitas Stoll, Andrea Seidel-Glätzer, Ina Burghaus, et al.
Frontiers in Immunology|December 29, 2025
Long-term compromised immune regulation after rituximab induction in blood group incompatible (ABOi) living-donor renal transplantation - 5 year results of a prospective pilot studyRolf Weimer, Hristos Karakizlis, Fabrice Renner, et al.
BMC Cancer|August 31, 2017
A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocolJacek Hajda, Monika Lehmann, Ottheinz Krebs, et al.
Pageof 11